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This study presents the results of HLA-DRB 1 typing of the eight monozygotic 
twin pairs with both members affected by rheumatoid arthritis (RA), sampled 
in the nationwide Finnish twin cohort. The shared epitope, associated with RA 
in case-control studies, was present in all eight twin pairs, being significantly 
more frequent than among RA patients in a recent Dutch case-control study. 
Furthermore, 4 out of 8 twin pairs were homozygous for the shared epitope, 
while in 73 Dutch healthy controls encoding the shared epitope only 13 (18%) 
were homozygous; this suggests a gene dose effect in RA susceptibility, Com­
bining these results with data from other sources may help to clarify the con­
tribution of HLA alleles in the genetic predisposition to RA.
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While early reports (1 ,2) showed an association of 
the serologically defined HLA-DR4 and -DR1 spec­
ificities with rheumatoid arthritis (RA), more recent 
case-control studies show that this disease is associ­
ated with HLA-DRB 1 alleles encoding a short 
structural motif in the third hyper variable region, 
the “ shared epitope” (SE). This shared epitope may 
be encoded by any of three highly homologous 
amino acid sequences at positions 67 to 74 of this 
molecule: LLEQKRAA, LLEQRRAA or LLERR 
RAA (single letter amino acid code: A = alanine, 
E = glutamic acid, K = lysine, L = leucine, 
Q = glutamine, R = arginine) (3,4).
While case control studies in the general popula­
tion help to define the association between DRB1 
alleles and disease susceptibility, data from diverse 
sources are needed to describe the genetic model for 
a given disease, e.g. mode of inheritance, the num­
ber of genes involved or the relative contribution of 
HLA to genetic predisposition. Twin studies, assess­
ing the frequency of disease concordance in mono- 
and dizygotic twins, are very informative in this re­
spect (5-9).
k
In RA, among the twin studies performed, the 
Finnish twin cohort study (6, 7) is unique in one as­
pect: By linking the Finnish twin cohort with the 
Sickness Insurance Register nearly all relevant
twins are included in the study, resulting in virtually 
complete ascertainment. In such a study the risk o f 
bias is reduced, e.g. concordant twin pairs are not 
more likely to enter the study than discordant pairs. 
Avoiding these biases is important when differenti­
ating between several genetic models. Since in RA 
these genetic models have to incorporate the effects 
of HLA-DRB 1 alleles on RA risk, we performed 
HLA-DRB 1 typing of the Finnish monozygotic 
concordant affected twins.
From 4137 monozygotic twin pairs, in total eight 
monozygotic twin pairs, both individuals fulfilling 
the 1987 criteria of the American College of Rheu­
matology for RA, were identified (6, 7). The sam­
pling procedure, zygosity testing and clinical char­
acteristics of these twins have been described else­
where (6, 7). All 16 twin members were seroposi­
tive at some stage, 14 had erosive disease, 12 had 
been treated with gold and 7 had rheumatoid nod­
ules. Peripheral blood was available from all indi­
viduals except patient 1A and 8B.
For HLA-typing DNA was isolated from periph­
eral blood, amplified in a polymerase chain reaction 
(PCR) using primers PI and P2 specific for exon 2 
(10), and screened using sequence specific (SSO) 
probes 1003 and 2810 described in the 11th work­
shop (11), probes 88-144, 88-148, 88-150, 88-151,
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Table 1
HLA-DRB1 alleles in 8 Finnish RA concordant affected monozygotic twins
Noa DR serology HLA-DRB1 age at onset sex RFb nodules erosive
#1 4 0404-13 46 48 F + + + + + +
#2 1,4 0101-0401 58 60 F + + + - + +
#3 1,5 0101-11 43 46 F + + —  — . —
#4 4 0401-0404 40 61 M + + + - + +
#5 3/6,4 03-0401 42 43 M + + — + +
#6 1,7 0101-07 39 40 F + + + + + +
#8 4 0401-0401 36 43 F + + — + +
#9 1,4 0101-0401 60 63 F + + + — + +
a Numbering as in Aho et al. (6), Pair #7 did not meet the ACR criteria and is left out of this analysis. 
b Rheumatoid factor positivity in some phase of disease (Latex and/or Waaler-Rose; see ref (7))
88-153, 89-55, 89-61 and 89-62 (10, 12) and 
probes 3, 4, 5, 6,10,11, 20, 21, 22 and 23 (13). Sub­
typing of the HLA-DR4 associated alleles was per­
formed using primers 336C and 337C, and SSO 
probes 152B, 153B, 156C, 157C, 315B, 769C, 
GT86 (14), probe 10 (13) and probe 102G with the 
sequence 5'-AGAGGAGTCCGTGCGCT-3' (Gen­
erously provided by JSS Lanchbury, London). In 
every screening procedure, SSO probes were end- 
labelled using T4-kinase (15), hybridized to the dot- 
blotted PCR product, stringency washed using 
TMAC1 (16), and detected by autoradiography. 
PCR-amplified DNA of homozygous typing cells 
from the Tenth International Histocompatibility 
Workshop was processed together with the samples 
to ascertain specific hybridization.
Table 1 shows the typing results of the eight 
monozygotic concordant affected twin pairs. When 
blood was available from both twins typing results 
were identical within twin pairs; results are there­
fore not separately presented. Of the eight twin pairs 
six were HLA-DR4 positive, while in all at least one 
HLA-DRB I allele encoded the shared epitope. Two 
twin pairs were homozygous for HLA-DR4, while 
in four pairs both HLA-DRB 1 alleles encoded the 
shared epitope. All individuals with rheumatoid 
nodules encoded the shared epitope amino acid
sequence LLEQRRAA (DRB 1*0404 or DRB1*
0101); no other associations of typing results with 
clinical features were observed.
To date, no HLA-DRB 1 typing data on Finnish 
RA patients are available; therefore typing results 
from a recent Dutch case-control study were used 
for reference. Compared to Dutch RA patients (17) 
the concordant monozygotic twins showed a signifi­
cantly higher allele frequency of the shared epitope 
(12/16 vj 159/334; Odd’s Ratio OR=4.72; confi­
dence interval CI=1.70-13.10; Fisher exact 
P=0.004), while the higher frequencies of 
HLA-DR4 (OR=2.15; P=0.17), of homozygosity for 
HLA-DR4 (OR=2.60; P=0.25) and of homozygosity
for SE (OR=3.28; P=0.10) did not reach signifi­
cance.
If homozygosity and heterozygosity for SE en­
code identical RA risks, the ratio between SE ho­
mozygous and heterozygous individuals should be 
identical in these monozygotic twin pairs and 
healthy controls. However, 4 in 8 monozygotic 
twins were homozygous for SE, while 13 in 73 SE- 
positive healthy controls were homozygous 
(OR=4.63; CI=1.02-20.89; P=0.05), thus support­
ing the concept that homozygosity for SE is associ­
ated with a higher RA risk.
Jawaheer et al. (9) reported earlier that concor­
dance in monozygotic twins is rare in the absence of 
the shared epitope. Our study confirms these find­
ings. Furthermore, it shows an increased frequency 
of homozygosity for the shared epitope alleles 
among these twins compared to normal controls, 
implicating a role for homozygosity in susceptibility 
to RA, in agreement with the HLA typing results in 
the UK nationwide RA twin study. This indicates 
that a genetic model for RA must include the effects 
of homozygosity. Combining the data presented 
here with HLA typing data and epidemiological 
data from other sources may help to clarify the role 
of HLA alleles in the genetic predisposition to RA.
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